1023 related articles for article (PubMed ID: 12662436)
21. Late effects of chemotherapy on hematopoietic progenitor cells.
Fried W; Adler S
Exp Hematol; 1985; 13 Suppl 16():49-56. PubMed ID: 3886419
[TBL] [Abstract][Full Text] [Related]
22. Effects of cyclophosphamide and of busulfan on spleen colony-forming units and on hematopoietic stroma.
Fried W; Kedo A; Barone J
Cancer Res; 1977 Apr; 37(4):1205-9. PubMed ID: 321118
[TBL] [Abstract][Full Text] [Related]
23. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
24. Cytokine gene expression in regenerating haematopoietic tissues of mice after cyclophosphamide treatment.
Psenák O; Sefc L; Sýkora V; Chang KT; Necas E
Acta Haematol; 2003; 109(2):68-75. PubMed ID: 12624490
[TBL] [Abstract][Full Text] [Related]
25. Genetic factors influencing murine hematopoietic productivity in culture.
Phillips RL; Couzens MS; Van Zant G
J Cell Physiol; 1995 Jul; 164(1):99-107. PubMed ID: 7790403
[TBL] [Abstract][Full Text] [Related]
26. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
[TBL] [Abstract][Full Text] [Related]
27. Effects of interleukin-6 on hematopoiesis in allogeneic and syngeneic bone marrow chimeras.
Imamura M; Han M; Hashino S; Kobayashi H; Imai K; Kobayashi M; Kobayashi S; Tanaka J; Kasai M; Sakurada K
Immunobiology; 1994 Aug; 191(1):21-37. PubMed ID: 7806257
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
Patchen ML; Vaudrain T; Correira H; Martin T; Reese D
Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381
[TBL] [Abstract][Full Text] [Related]
29. Leukopenia and altered hematopoietic activity in mice exposed to the abused inhalant, isobutyl nitrite.
Soderberg LS; Flick JT; Barnett JB
Exp Hematol; 1996 Jun; 24(7):848-53. PubMed ID: 8647236
[TBL] [Abstract][Full Text] [Related]
30. Effects of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of murine late spleen colony-forming cells (day-12 CFU-S) and hematopoietic repopulating cells to mafosfamide (ASTA Z 7557).
Kohn FR; Sladek NE
Biochem Pharmacol; 1987 Sep; 36(17):2805-11. PubMed ID: 2820422
[TBL] [Abstract][Full Text] [Related]
31. In vivo modulation of hematopoiesis by a novel hematoregulatory peptide.
Pelus LM; King AG; Broxmeyer HE; DeMarsh PL; Petteway SR; Bhatnagar PK
Exp Hematol; 1994 Mar; 22(3):239-47. PubMed ID: 8112423
[TBL] [Abstract][Full Text] [Related]
32. [Effect of cyclophosphamide on the bone marrow hematopoiesis in the mouse].
Xie RF
Zhonghua Zhong Liu Za Zhi; 1985 Nov; 7(6):435-7. PubMed ID: 3836845
[TBL] [Abstract][Full Text] [Related]
33. Preferential differentiation of murine CFU-S toward granulopoiesis and megakaryocytopoiesis after in vitro incubation of bone marrow with ASTA-Z 7557.
Sainteny F; Lopez M; Mary JY; Frindel E
Exp Hematol; 1987 Jul; 15(6):631-5. PubMed ID: 3297759
[TBL] [Abstract][Full Text] [Related]
34. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
Gallicchio VS; Hughes NK; Tse KF
Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
[TBL] [Abstract][Full Text] [Related]
35. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
36. Temporal response of murine pluripotent stem cells and myeloid and erythroid progenitor cells to low-dose glucan treatment.
Patchen ML; MacVittie TJ
Acta Haematol; 1983; 70(5):281-8. PubMed ID: 6414220
[TBL] [Abstract][Full Text] [Related]
37. Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro.
Song H; Vita M; Sallam H; Tehranchi R; Nilsson C; Sidén A; Hassan Z
Cancer Chemother Pharmacol; 2007 Nov; 60(6):841-9. PubMed ID: 17318617
[TBL] [Abstract][Full Text] [Related]
38. Myelosuppressive effects in vivo with very low dosages of monomeric recombinant murine macrophage inflammatory protein-1 alpha.
Cooper S; Mantel C; Broxmeyer HE
Exp Hematol; 1994 Feb; 22(2):186-93. PubMed ID: 8299739
[TBL] [Abstract][Full Text] [Related]
39. Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood.
Van Zant G; Rummel SA; Koller MR; Larson DB; Drubachevsky I; Palsson M; Emerson SG
Blood Cells; 1994; 20(2-3):482-90; discussion 491. PubMed ID: 7538353
[TBL] [Abstract][Full Text] [Related]
40. In vivo effects of the immunosuppressant 15-deoxyspergualin on hematopoiesis in murine allogeneic bone marrow chimeras. Its thrombopoietic activity and reversal of adverse effects with granulocyte colony-stimulating factor and/or erythropoietin.
Imamura M; Han M; Hashino S; Kobayashi H; Imai K; Kobayashi S; Tanaka J; Zhu X; Kobayashi M; Fujii Y
Transplantation; 1994 Jul; 58(2):214-23. PubMed ID: 7518976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
